The NAv1.7 blocker protoxin II reduces burn injury-induced spinal nociceptive processing

J Mol Med (Berl). 2018 Jan;96(1):75-84. doi: 10.1007/s00109-017-1599-0. Epub 2017 Oct 23.

Abstract

Controlling pain in burn-injured patients poses a major clinical challenge. Recent findings suggest that reducing the activity of the voltage-gated sodium channel Nav1.7 in primary sensory neurons could provide improved pain control in burn-injured patients. Here, we report that partial thickness scalding-type burn injury on the rat paw upregulates Nav1.7 expression in primary sensory neurons 3 h following injury. The injury also induces upregulation in phosphorylated cyclic adenosine monophosphate response element-binding protein (p-CREB), a marker for nociceptive activation in primary sensory neurons. The upregulation in p-CREB occurs mainly in Nav1.7-immunopositive neurons and exhibits a peak at 5 min and, following a decline at 30 min, a gradual increase from 1 h post-injury. The Nav1.7 blocker protoxin II (ProTxII) or morphine injected intraperitoneally 15 min before or after the injury significantly reduces burn injury-induced spinal upregulation in phosphorylated serine 10 in histone H3 and phosphorylated extracellular signal-regulated kinase 1/2, which are both markers for spinal nociceptive processing. Further, ProTxII significantly reduces the frequency of spontaneous excitatory post-synaptic currents in spinal dorsal horn neurons following burn injury. Together, these findings indicate that using Nav1.7 blockers should be considered to control pain in burn injury.

Key messages: • Burn injury upregulates Nav1.7 expression in primary sensory neurons. • Burn injury results in increased activity of Nav1.7-expressing primary sensory neurons. • Inhibiting Nav1.7 by protoxin II reduces spinal nociceptive processing. • Nav1.7 represents a potential target to reduce pain in burn injury.

Keywords: Pain; Primary sensory neuron; Spinal cord; p-ERK1/2; p-S10H3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / therapeutic use*
  • Animals
  • Burns / drug therapy*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NAV1.7 Voltage-Gated Sodium Channel / physiology*
  • Pain / drug therapy*
  • Peptides / therapeutic use*
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Sensory Receptor Cells / physiology
  • Spider Venoms / therapeutic use*
  • Spinal Cord / cytology
  • Spinal Cord / physiology
  • Voltage-Gated Sodium Channel Blockers / therapeutic use*

Substances

  • Analgesics
  • Cyclic AMP Response Element-Binding Protein
  • NAV1.7 Voltage-Gated Sodium Channel
  • Peptides
  • Spider Venoms
  • Voltage-Gated Sodium Channel Blockers
  • protoxin II, Thrixopelma pruriens